LOX Antibody - BSA Free

Immunohistochemistry: LOX Antibody - BSA Free [NB100-2530]

Immunohistochemistry: LOX Antibody [NB100-2530] - Human placental villi, 40X. Staining of placental trophoblasts using NB100-2530 at 10 ug/ml.

Simple Western: LOX AntibodyBSA Free [NB100-2530]

Simple Western: LOX Antibody [NB100-2530] - Simple Western lane view shows a specific band for Lox in 0.5 mg/ml of HeLa lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system.

Immunohistochemistry: LOX Antibody - BSA Free [NB100-2530] -

Expression of LOX in primary nasopharyngeal carcinoma (IHC staining) Strong expression(a) magnification, ×200; (A) magnification, ×400; Moderate expression: (b) magnification, ×200; (B) magnification, ×400; Weak expression: (c) magnification, ×200; (C) magnification, ×400; Negative: (d) magnification, ×200; (D) magnification, ×400.

Immunohistochemistry: LOX Antibody - BSA Free [NB100-2530] -

Immunohistochemistry: LOX Antibody - BSA Free [NB100-2530] - alpha-SMA, LOX, & COL1A1 immunostaining in human thyroid cancers. Representative thyroid tumors serial sections from two different patients stained by IHC for alpha-SMA, COL1A1, & LOX protein expression & localization. In the top panel, the tumor edge/invasive front is specifically shown (scale bar 500 µm), while lower panel has higher magnification (scale bar 200 µm). * clusters of tumor invading cells detaching from the principal tumor mass (T). Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/31906302), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Immunohistochemistry: LOX Antibody - BSA Free [NB100-2530] -

Immunohistochemistry: LOX Antibody - BSA Free [NB100-2530] - Expression of LOX in primary nasopharyngeal carcinoma (IHC staining) Strong expression(a) magnification, ×200; (A) magnification, ×400; Moderate expression: (b) magnification, ×200; (B) magnification, ×400; Weak expression: (c) magnification, ×200; (C) magnification, ×400; Negative: (d) magnification, ×200; (D) magnification, ×400. Image collected & cropped by CiteAb from the following publication (https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.6996), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Immunohistochemistry: LOX Antibody - BSA Free [NB100-2530] -

Immunohistochemistry: LOX Antibody - BSA Free [NB100-2530] - alpha-SMA, LOX, & COL1A1 immunostaining in human thyroid cancers. Representative thyroid tumors serial sections from two different patients stained by IHC for alpha-SMA, COL1A1, & LOX protein expression & localization. In the top panel, the tumor edge/invasive front is specifically shown (scale bar 500 µm), while lower panel has higher magnification (scale bar 200 µm). * clusters of tumor invading cells detaching from the principal tumor mass (T). Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/31906302), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Immunohistochemistry-Paraffin: LOX Antibody - BSA Free [NB100-2530] -

Immunohistochemistry-Paraffin: LOX Antibody - BSA Free [NB100-2530] - Elastin & elastin-related proteins. Tile scans of sheep aortic valve sections stained with Russell Movat's pentachrome (mature elastic fibers in black) & antibodies against proteins involved in elastic fiber formation, including the core protein (tropo)elastin, fibronectin, the microfibrillar proteins fibrillin-1 & fibrillin-2, & cross-linking proteins fibulin-4, fibulin-5, lysyl oxidase (LOX), & Elastin microfibril interfacer 1 (EMILIN-1). Scale bars, 1 mm. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/30159315), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Immunohistochemistry-Paraffin: LOX Antibody - BSA Free [NB100-2530] -

Immunohistochemistry-Paraffin: LOX Antibody - BSA Free [NB100-2530] - Lysyl Oxidase (LOX) expression in malignant & non-malignant human prostate tissue.(A) Representative immunohistochemical staining of LOX (brown) in sections of non-malignant prostate tissue specimens (TINT epithelium & TINT stroma) from two prostate cancer patients (original magnifications x 200). Case A show weak epithelial staining (score 1) & Case B strong epithelial staining (score 3). (B) Consecutive sections from non-malignant prostate tissue stained with in situ hybridization or immunohistochemistry for LOX. Note that mRNA (brown dots) & protein (brown) expression in individual glands were related, in the stroma in contrast mRNA was generally low but protein often detected (original magnifications x200). (C) LOX mRNA expression in non-malignant prostate tissue (TINT) (n = 12), in primary prostate tumor tissue (n = 12), & in castration-resistant bone metastases (CRPC) (n = 30) using Illumina gene expression array. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/26501565), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Immunohistochemistry-Paraffin: LOX Antibody - BSA Free [NB100-2530] -

Immunohistochemistry-Paraffin: LOX Antibody - BSA Free [NB100-2530] - Lysyl Oxidase (LOX) expression in malignant & non-malignant human prostate tissue.(A) Representative immunohistochemical staining of LOX (brown) in sections of non-malignant prostate tissue specimens (TINT epithelium & TINT stroma) from two prostate cancer patients (original magnifications x 200). Case A show weak epithelial staining (score 1) & Case B strong epithelial staining (score 3). (B) Consecutive sections from non-malignant prostate tissue stained with in situ hybridization or immunohistochemistry for LOX. Note that mRNA (brown dots) & protein (brown) expression in individual glands were related, in the stroma in contrast mRNA was generally low but protein often detected (original magnifications x200). (C) LOX mRNA expression in non-malignant prostate tissue (TINT) (n = 12), in primary prostate tumor tissue (n = 12), & in castration-resistant bone metastases (CRPC) (n = 30) using Illumina gene expression array. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/26501565), licensed under a CC-BY license. Not internally tested by Novus Biologicals.